{"id":285838,"date":"2026-10-05T10:17:23","date_gmt":"2026-10-05T04:47:23","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=285838"},"modified":"2026-10-05T10:17:23","modified_gmt":"2026-10-05T04:47:23","slug":"nglfine-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/nglfine-best-stock-in-its-sector\/","title":{"rendered":"Is NGL Fine-Chem the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"

NGL Fine-Chem CMP Rs 2,930 (05 Oct 2026). Market cap Rs 1,808 Cr. ROE 14.62%. P\/E 31.61x versus Industry P\/E 37.53x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

NGL Fine-Chem is one of the names investors compare when screening the Healthcare sector, built on a 14.62% return on equity and a P\/E of 31.61x against an Industry P\/E of 37.53x. Whether NGL Fine-Chem is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n

Is NGL Fine-Chem<\/a> the best stock in its sector? The stock trades on the NSE at Rs 2,930 as of 05 October 2026, within its 52-week range of Rs 1,271.00 to Rs 3,602.00. NGL Fine-Chem Ltd manufactures veterinary and human active pharmaceutical ingredients, intermediates and finished formulations, with veterinary APIs the bulk of its business.<\/p>\n

NGL Fine-Chem sits in the Healthcare sector, and its 14.62% ROE and 31.61x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P\/E benchmark.<\/p>\n

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n